Literature DB >> 10163329

Glaucoma risk factors observed in the Baltimore Eye Survey.

A Sommer1.   

Abstract

The Baltimore Eye Survey identified race, intraocular pressure, systemic hypertension, perfusion pressure, family history, and quite possibly the structure and organization of the optic nerve head as potential etiologically significant risk factors in the development of glaucomatous optic nerve damage. These findings have been confirmed by subsequent, sometimes equally rigorous population-based studies in other communities and countries. The Baltimore Eye Survey failed to demonstrate a role for diabetes but revealed that estimates of the significance of diabetes, like that of family history, are subject to considerable selection bias.

Entities:  

Mesh:

Year:  1996        PMID: 10163329     DOI: 10.1097/00055735-199604000-00016

Source DB:  PubMed          Journal:  Curr Opin Ophthalmol        ISSN: 1040-8738            Impact factor:   3.761


  39 in total

Review 1.  A hypothesis to explain ganglion cell death caused by vascular insults at the optic nerve head: possible implication for the treatment of glaucoma.

Authors:  N N Osborne; J Melena; G Chidlow; J P Wood
Journal:  Br J Ophthalmol       Date:  2001-10       Impact factor: 4.638

2.  African Descent and Glaucoma Evaluation Study (ADAGES): II. Ancestry differences in optic disc, retinal nerve fiber layer, and macular structure in healthy subjects.

Authors:  Christopher A Girkin; Pamela A Sample; Jeffrey M Liebmann; Sonia Jain; Christopher Bowd; Lida M Becerra; Felipe A Medeiros; Lyne Racette; Keri A Dirkes; Robert N Weinreb; Linda M Zangwill
Journal:  Arch Ophthalmol       Date:  2010-05

3.  Axial length and optic disc size in normal eyes.

Authors:  C Oliveira; N Harizman; C A Girkin; A Xie; C Tello; J M Liebmann; R Ritch
Journal:  Br J Ophthalmol       Date:  2006-09-20       Impact factor: 4.638

4.  [Presentation of software for collation of inpatient diurnal pressure profiles in glaucoma patients].

Authors:  S Christmann; C Leisser; N Schrage
Journal:  Ophthalmologe       Date:  2014-02       Impact factor: 1.059

5.  Is Obstructive Sleep Apnea Associated With Progressive Glaucomatous Optic Neuropathy?

Authors:  Swarup S Swaminathan; Amitabha S Bhakta; Wei Shi; William J Feuer; Alexandre R Abreu; Alejandro D Chediak; David S Greenfield
Journal:  J Glaucoma       Date:  2018-01       Impact factor: 2.503

6.  Variation of laminar depth in normal eyes with age and race.

Authors:  Lindsay A Rhodes; Carrie Huisingh; John Johnstone; Massimo Fazio; Brandon Smith; Mark Clark; J Crawford Downs; Cynthia Owsley; Michael J A Girard; Jean Martial Mari; Christopher Girkin
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-11-20       Impact factor: 4.799

7.  African descent and glaucoma evaluation study: asymmetry of structural measures in normal participants.

Authors:  Grant H Moore; Christopher Bowd; Felipe A Medeiros; Pamela A Sample; Jeffrey M Liebmann; Christopher A Girkin; Mauro T Leite; Robert N Weinreb; Linda M Zangwill
Journal:  J Glaucoma       Date:  2013-02       Impact factor: 2.503

8.  Improving Access to Eye Care among Persons at High-Risk of Glaucoma in Philadelphia--Design and Methodology: The Philadelphia Glaucoma Detection and Treatment Project.

Authors:  Lisa Hark; Michael Waisbourd; Jonathan S Myers; Jeffrey Henderer; John E Crews; Jinan B Saaddine; Jeanne Molineaux; Deiana Johnson; Harjeet Sembhi; Shayla Stratford; Ayman Suleiman; Laura Pizzi; George L Spaeth; L Jay Katz
Journal:  Ophthalmic Epidemiol       Date:  2016-03-07       Impact factor: 1.648

9.  Vascular risk factors for open angle glaucoma in african eyes.

Authors:  Afekhide E Omoti; Malachi E Enock; Valentina W Okeigbemen; Benedicta A Akpe; Ukamaka C Fuh
Journal:  Middle East Afr J Ophthalmol       Date:  2009-07

10.  Copy number variation at chromosome 5q21.2 is associated with intraocular pressure.

Authors:  Abhishek Nag; Cristina Venturini; Pirro G Hysi; Matthew Arno; Estibaliz Aldecoa-Otalora Astarloa; Stuart Macgregor; Alex W Hewitt; Terri L Young; Paul Mitchell; Ananth C Viswanathan; David A Mackey; Christopher J Hammond
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-05-01       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.